Trial intelligence / Profile preview

GSK576389A Influenza Vaccine Formulations Study

NCT00633074Phase 2Completed

Sponsor
GSK
Start
Mar 2008
Primary completion
Apr 2008
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of GSK576389A in influenza, sponsored by GSK. Started Mar 2008; status: completed.

02

Drugs

GSK576389A
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00633074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00633074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call